Home/Filings/4/0000899243-21-018114
4//SEC Filing

Isaacs Randi 4

Accession 0000899243-21-018114

CIK 0001785530other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 4:30 PM ET

Size

10.3 KB

Accession

0000899243-21-018114

Insider Transaction Report

Form 4
Period: 2020-11-09
Isaacs Randi
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-11-09+176,966176,966 total
    Exercise: $3.03Exp: 2030-11-08Common Stock (176,966 underlying)
  • Award

    Stock Option (right to buy)

    2021-04-30+56,78656,786 total
    Exercise: $16.00Exp: 2031-04-29Common Stock (56,786 underlying)
  • Award

    Stock Option (right to buy)

    2020-12-08+140,208140,208 total
    Exercise: $4.77Exp: 2030-12-07Common Stock (140,208 underlying)
Footnotes (3)
  • [F1]The option was granted on November 9, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through November 9, 2024.
  • [F2]The option was granted on December 8, 2020. The shares underlying the option vest over four years, with 25% of the shares vesting on the first anniversary of the grant date and 2.0833% of the shares vesting each month thereafter through December 8, 2024.
  • [F3]The option was granted on April 30, 2021. The shares underlying the option vest over four years in equal monthly installments through April 30, 2025.

Issuer

Werewolf Therapeutics, Inc.

CIK 0001785530

Entity typeother

Related Parties

1
  • filerCIK 0001857797

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:30 PM ET
Size
10.3 KB